Sugi Predict

Sugi Predict / Compounds / SCHEMBL30490596

SCHEMBL30490596

SCHEMBL30490596

C[C@@H](O)[C@H](N)C(=O)N[C@H](CCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 17/20 0.55
▸ NPY1R P25929 10/20 0.55
▸ NPY5R Q15761 9/20 0.55
▸ NPY2R P49146 6/20 0.55
▸ IL23R Q5VWK5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29415142 0.92 IL23R (0.53) NPY4RNPY1RNPY5RNPY2RIL23R
SCHEMBL30882728 0.92 MME (0.50) NPY4RNPY1RNPY2R
SCHEMBL30361669 0.90 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30368148 0.90 NPY4R (0.63) NPY4RNPY1RNPY5RNPY2R
SCHEMBL32672584 0.90 NPY4R (0.61) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30368024 0.90 NPY4R (0.63) NPY4RNPY1RNPY5RNPY2R
SCHEMBL29415168 0.90 NPY4R (0.60) NPY4RNPY1RNPY5RNPY2RIL23R
SCHEMBL30490559 0.90 NPY4R (0.58) NPY4RNPY1RNPY5RNPY2RIL23R
SCHEMBL30367902 0.90 NPY4R (0.57) NPY4RNPY1RNPY5RNPY2R
SCHEMBL30368147 0.90 NPY4R (0.62) NPY4RNPY1RNPY5RNPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295234-A1 ANTIMICROBIAL PEPTIDOMIMETICS SPEXIS AG (CH) 2023-09-21 — — US claimed
EP-4214221-A1 ANTIMICROBIAL PEPTIDOMIMETICS Spexis AG (CH) 2023-07-26 — — EP claimed
US-20230295234-A1 ANTIMICROBIAL PEPTIDOMIMETICS SPEXIS AG (CH) 2023-09-21 — — US disclosed
EP-4214221-A1 ANTIMICROBIAL PEPTIDOMIMETICS Spexis AG (CH) 2023-07-26 — — EP disclosed
Send feedback